tiprankstipranks
Trending News
More News >
Lotus Eye Hospital And Institute Ltd (IN:LOTUSEYE)
:LOTUSEYE
India Market
Advertisement

Lotus Eye Hospital And Institute Ltd (LOTUSEYE) Financial Statements

Compare
0 Followers

Lotus Eye Hospital And Institute Ltd Financial Overview

Lotus Eye Hospital And Institute Ltd's market cap is currently ₹1.64B. The company's EPS TTM is ₹0.12; its P/E ratio is 217.19; and it has a dividend yield of 0.72%. Lotus Eye Hospital And Institute Ltd is scheduled to report earnings on May 29, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Mar 24Mar 23Mar 22Mar 21
Income Statement
Total Revenue₹ 495.63M₹ 482.10M₹ 470.44M₹ 380.86M₹ 316.67M
Gross Profit₹ 100.41M₹ 135.66M₹ 243.17M₹ 192.53M₹ 160.14M
Operating Income₹ 4.26M₹ 100.55M₹ 47.13M₹ 34.67M₹ 13.17M
EBITDA₹ 47.44M₹ 79.42M₹ 88.37M₹ 68.09M₹ 44.59M
Net Income₹ 7.39M₹ 29.14M₹ 40.77M₹ 29.84M₹ 15.68M
Balance Sheet
Cash & Short-Term Investments₹ 41.51M₹ 69.30M₹ 83.31M₹ 87.93M₹ 98.92M
Total Assets₹ 695.74M₹ 666.27M₹ 631.88M₹ 615.97M₹ 592.29M
Total Debt₹ 34.30M₹ 11.10M₹ 6.70M₹ 12.38M₹ 3.99M
Net Debt₹ -7.21M₹ -15.42M₹ -29.33M₹ -25.51M₹ -47.82M
Total Liabilities₹ 95.73M₹ 72.17M₹ 56.09M₹ 69.88M₹ 65.32M
Stockholders' Equity₹ 600.00M₹ 594.09M₹ 575.79M₹ 546.09M₹ 526.97M
Cash Flow
Free Cash Flow₹ -21.25M₹ 403.00K₹ 12.90M₹ -2.73M₹ 22.55M
Operating Cash Flow₹ 27.02M₹ 56.83M₹ 43.87M₹ 44.12M₹ 27.30M
Investing Cash Flow₹ -43.50M₹ -46.33M₹ -21.94M₹ -39.35M₹ 4.86M
Financing Cash Flow₹ -12.42M₹ -34.02M₹ -17.05M₹ -15.75M₹ -3.19M
Currency in INR

Lotus Eye Hospital And Institute Ltd Earnings and Revenue History

Lotus Eye Hospital And Institute Ltd Debt to Assets

Lotus Eye Hospital And Institute Ltd Cash Flow

Lotus Eye Hospital And Institute Ltd Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis